Crown Advisors Management’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
Other funds holding AYTU
AIC
Crown Advisors Management's AYTU Position: Q3 2026 in Review
Crown Advisors Management held its AYTU BioPharma (AYTU) position steady in Q3 2026 at 200,000 shares worth $428K. The position accounts for 0.3% of the portfolio, ranked #42.
Crown Advisors Management first reported a position in AYTU in Q1 2026 and has held it in 3 quarters since. The position peaked at $430K in Q2 2026. 36 funds tracked by Wall St. Rank hold AYTU as of Q3 2026.
- Crown Advisors Management held 200,000 shares of AYTU BioPharma worth $428K as of Q3 2026.
- Crown Advisors Management left its AYTU BioPharma share count unchanged in Q3 2026.
- AYTU BioPharma made up 0.3% of Crown Advisors Management's portfolio in Q3 2026, its #42 holding.
- Crown Advisors Management first reported a position in AYTU BioPharma in Q1 2026 and has held it in 3 quarters since.
- Crown Advisors Management's AYTU BioPharma position peaked at $430K in Q2 2026.
- 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2026.
Based on Crown Advisors Management's 13F filing for Q3 2026, filed 12 Nov 2026.